Saltar al contenido
Merck

Surgical management of placenta accreta: to leave or remove the placenta?

BJOG : an international journal of obstetrics and gynaecology (2014-01-01)
A Perez-Delboy, J D Wright
RESUMEN

Abnromalities of placentation, including placenta accreta, represent a major source of morbidity and mortality among women. Traditional management consists of peripartum hysterectomy at the time of delivery, although more conservative treatments have also been developed recently. In this review we describe the available literature describing the operative approach and considerations for management of women with placenta accreta.

MATERIALES
Número de producto
Marca
Descripción del producto

Sigma-Aldrich
Metotrexato hydrate, ≥98% (HPLC), powder
Sigma-Aldrich
Metotrexato hydrate, powder, BioReagent, suitable for cell culture, ≥98% (HPLC)
Sigma-Aldrich
Metotrexato hydrate, meets USP testing specifications
Supelco
Methotrexate solution, 1.0 mg/mL in methanol with 0.1N NaOH, ampule of 1 mL, certified reference material, Cerilliant®
Methotrexate, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Metotrexato hydrate, ≥99.0% (sum of enantiomers, HPLC)
Methotrexate for peak identification, European Pharmacopoeia (EP) Reference Standard